Product Categories
| Country: | China |
|---|---|
| Tel: | 177-54423994 |
| Mobile: | 17754423994 |
| E-mail: | 2853530910@QQ.com |
| QQ: | 2853530910 |
| Skype: | Chat Now! |
| Product Name | MF | CAS | Details |
|---|
| 2-(4-Bromo-2,6-dimethylphenyl)acetonitrile | C10H10BrN | 205035-09-2 | Details |
| Tert-butyl [2-(4-amino-1H-pyrazol-1-yl)ethyl]carbamate oxalate | C12H20N4O6 | 1965304-61-3 | Details |
| Methyl 10,11-dihydro-5H-dibenzo[b,f]azepine-4-carboxylate | C16H15NO2 | 22965-12-4 | Details |
| SSD114 | C18H20F3N3O | 554428-55-6 | Details |
| 5,6-Dibromo-2,3-dimethylpyridine | C7H7Br2N | 117846-56-7 | Details |
| 3-Pyridinecarboxamide, 1,4-dihydro-1-methyl-N-(5-nitro-1,2-benzisothiazol-3-yl)-4-oxo- | C14H10N4O4S | 1821309-39-0 | Details |
| GSK3685032 | C22H24N6OS | 2170137-61-6 | Details |
| TSHR antagonist S37 | C25H20N2O3S2 | 1217616-61-9 | Details |
| Apixaban Impurity 38 | C10H16Cl2O3 | 1802522-36-6 | Details |
| PBD dimer | C42H39N5O7 | 1222490-34-7 | Details |
| 4-[2-(2,6-dioxo-3-piperidinyl)-6-fluoro-2,3-dihydro-1,3-dioxo-1Hisoindol-5-yl]-, 1,1-dimethylethyl ester-1-Piperazinecarboxylic acid | C22H25FN4O6 | 2222116-02-9 | Details |
| (2-fluoro-3-methoxy-6-(1H-tetrazol-1-yl)phenyl)methanamine | C9H10FN5O | 1821248-00-3 | Details |
| NE10790 | C8H10NO6P | 152831-36-2 | Details |
| WAY-181187 hydrochloride | C15H14Cl2N4O2S2 | 554403-08-6 | Details |
| FLT3-IN-3 | C27H38N8O | 2229050-90-0 | Details |
| TY-52156 | C18H19Cl2N3O | 934369-14-9 | Details |
| Phentolamine Analogue 1 | C17H19N3O | 47142-51-8 | Details |
| 6-Cyclopropyl-1-isopropyl-1H-pyrazolo[3,4-b]pyridine-4-carboxylic acid | C13H15N3O2 | 851288-57-8 | Details |
| Ebastine Impurity G | C32H39NO3 | 1429071-65-7 | Details |
| Budesonide Impurity 7 | C23H28O7 | 3949-79-9 | Details |
| Ebastine Impurity F | C32H39NO3 | 1429071-63-5 | Details |
| Daunomycinone | C21H18O8 | 21794-55-8 | Details |
| BMS-986176 | C19H23F4N3O | 1815613-42-3 | Details |
| TBI-166 | C32H30F3N5O3 | 1353734-12-9 | Details |
| UNC6934 | C24H21N5O4 | 2561494-77-5 | Details |
| SJ-172550 | C22H21ClN2O5 | 431979-47-4 | Details |
| CR8, (R)-Isomer | C24H29N7O | 294646-77-8 | Details |
| (R)-CR8 trihydrochloride | C24H30ClN7O | 1786438-30-9 | Details |
| FIDAS-3 | C16H15F2N | 1266684-01-8 | Details |
| Ibalizumab | 680188-33-4 | Details |
| Panobacumab | 885053-97-4 | Details |
| Tigatuzumab | 918127-53-4 | Details |
| Otelixizumab | 881191-44-2 | Details |
| I-BET567 | C17H18ClN5O2 | 1887237-54-8 | Details |
| NVR-3-778 | C18H16F4N2O4S | 1445790-55-5 | Details |
| Raxibacumab | 565451-13-0 | Details |
| Besilesomab | 537694-98-7 | Details |
| Volociximab | 558480-40-3 | Details |
| Yttrium (90Y) Tacatuzumab Tetraxetan | 476413-07-7 | Details |
| Pagibaximab | 595566-61-3 | Details |
| Bapineuzumab | 648895-38-9 | Details |
| Sontuzumab | 372075-37-1 | Details |
| Iratumumab | 640735-09-7 | Details |
| Disitamab Vedotin | 2136633-23-1 | Details |
| Libivirumab | 569658-79-3 | Details |
| Exbivirumab | 569658-80-6 | Details |
| Tefibazumab | 521079-87-8 | Details |
| Edrecolomab | 156586-89-9 | Details |
| HLY78 | C17H17NO2 | 854847-61-3 | Details |
| BVT948 | C14H11NO3 | 39674-97-0 | Details |
| GSK 2033 | C29H28F3NO5S2 | 1221277-90-2 | Details |
| 7-O-(Triethylsilyl) Baccatin III | C37H52O11Si | 115437-21-3 | Details |
| YH53 | C30H33N5O5S | 1471484-62-4 | Details |
| Erlizumab | 211323-03-4 | Details |
| Reslizumab | 241473-69-8 | Details |
| Vapaliximab | 336801-86-6 | Details |
| Ecromeximab | 292819-64-8 | Details |
| Teneliximab | 395639-53-9 | Details |
| Pritumumab | 499212-74-7 | Details |
| elsilimomab | 468715-71-1 | Details |
| Oxelumab | 1186098-83-8 | Details |
| SIS3 | C28H27N3O3 | 1009104-85-1 | Details |
| RGD Trifluoroacetate | C14H23F3N6O8 | 2378808-45-6 | Details |
| EIT hydrobromide | C3H9BrN2S | 1071-37-0 | Details |
| Rilotumumab | 872514-65-3 | Details |
| Robatumumab | 934235-44-6 | Details |
| Figitumumab | 943453-46-1 | Details |
| Farletuzuma | 896723-44-7 | Details |
| Elotuzumab | 915296-00-3 | Details |
| Cixutumumab | 947687-12-9 | Details |
| Anatumomab | Details |
| Sibrotuzumab | 216669-97-5 | Details |
| Bivatuzumab | Details |
| Lemalesomab | 250242-54-7 | Details |
| Olokizumab | 1007223-17-7 | Details |
| Itolizumab | 1116433-11-4 | Details |
| Foralumab | 946415-64-1 | Details |
| Ensituximab | 1092658-06-4 | Details |
| Drozitumab | 912628-39-8 | Details |
| Teprotumumab | 1036734-93-6 | Details |
| Mavrilimumab | 1085337-57-0 | Details |
| Dalotuzumab | 1005389-60-5 | Details |
| Glembatumumab | 1020264-78-1 | Details |
| Suvizumab | 914257-21-9 | Details |
| Girentuximab | 916138-87-9 | Details |
| Rontalizumab | 948570-30-7 | Details |
| Lebrikizumab | 953400-68-5 | Details |
| Fezakinumab | 1007106-86-6 | Details |
| Sifalimumab | 1006877-41-3 | Details |
| Intetumumab | 725735-28-4 | Details |
| Maslimomab | 127757-92-0 | Details |
| Altumomab | 156586-92-4 | Details |
| Morolimumab | Details |
| Vepalimomab | 195158-85-1 | Details |
| Minretumomab | 195189-17-4 | Details |
| Nerelimomab | 162774-06-3 | Details |
| Bectumomab | 158318-63-9 | Details |
| Faralimomab | 167816-91-3 | Details |
| Rovelizumab | 339086-79-2 | Details |
| Mogamulizumab | 1159266-37-1 | Details |
| Product Total： Product Page： | ||||
| 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 66 67 68 69 70 71 72 73 74 75 76 77 78 79 80 | ||||